CorMedix (CRMD) Research & Development (2016 - 2025)
Historic Research & Development for CorMedix (CRMD) over the last 13 years, with Q3 2025 value amounting to $5.1 million.
- CorMedix's Research & Development rose 60107.42% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.5 million, marking a year-over-year increase of 15534.26%. This contributed to the annual value of $3.9 million for FY2024, which is 7003.24% down from last year.
- CorMedix's Research & Development amounted to $5.1 million in Q3 2025, which was up 60107.42% from $2.4 million recorded in Q2 2025.
- In the past 5 years, CorMedix's Research & Development registered a high of $5.1 million during Q3 2025, and its lowest value of $650988.0 during Q2 2024.
- Its 5-year average for Research & Development is $2.7 million, with a median of $2.7 million in 2021.
- Per our database at Business Quant, CorMedix's Research & Development crashed by 8642.29% in 2024 and then soared by 60107.42% in 2025.
- CorMedix's Research & Development (Quarter) stood at $3.2 million in 2021, then dropped by 12.12% to $2.8 million in 2022, then dropped by 6.3% to $2.7 million in 2023, then crashed by 35.18% to $1.7 million in 2024, then skyrocketed by 195.22% to $5.1 million in 2025.
- Its Research & Development stands at $5.1 million for Q3 2025, versus $2.4 million for Q2 2025 and $3.2 million for Q1 2025.